# Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam

> **NCT01768273** · PHASE1 · COMPLETED · sponsor: **Global Alliance for TB Drug Development** · enrollment: 14 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Midazolam
- **DRUG:** PA-824

## Key facts

- **NCT ID:** NCT01768273
- **Lead sponsor:** Global Alliance for TB Drug Development
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01768273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01768273, "Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01768273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*